1 Coull AJ，Lovett JK，Rothwell PM. Population based

study of early risk of stroke after transient ischaemic attack or minor stroke：implications for public

education and organisation of services[J]. BMJ，2004，

328：326.

2 Wang Y，Wang Y，Zhao X，et al. Clopidogrel with

aspirin in acute minor stroke or transient ischemic

attack[J]. N Engl J Med，2013，369：11-19.

3 Shobha N，Fang J，Hill MD. Do lacunar strokes

benef it from thrombolysis? Evidence from the

Registry of the Canadian Stroke Network[J]. Int J

Stroke，2013，8：45-49.

4 Liu L，Wang D，Wong KS，et al. Stroke and stroke

care in china：huge burden, significant workload，and

a national priority[J]. Stroke，2011，42：3651-3654.

5 Wang Y，Zhao X，Jiang Y，et al. Prevalence，

knowledge，and treatment of transient ischemic

attacks in China[J]. Neurology，2015，84：2354-2361.

6 Kernan WN，Horwitz RI，Brass LM，et al. A prognostic

system for transient ischemia or minor stroke[J]. Ann

Intern Med，1991，114：552-557.

7 Committee CS. A randomized，blinded，trial of

clopidogrel versus aspirin in patients at risk of

ischaemic events (CAPRIE). CAPRIE Steering

Committee[J]. Lancet，1996，348：1329-1339.

8 Johnston SC，Gress DR，Browner WS，et al. Shortterm

prognosis after emergency department diagnosis

of TIA[J]. JAMA，2000，284：2901-2906.

9 Kernan WN，Viscoli CM，Brass LM，et al. The stroke

prognosis instrument II (SPI-II)：A clinical prediction

instrument for patients with transient ischemia and

nondisabling ischemic stroke[J]. Stroke，2000，31：

456-462.

10 Johnston SC，Rothwell PM，Nguyen-Huynh MN，et

al. Validation and refinement of scores to predict very

early stroke risk after transient ischaemic attack[J].

Lancet，2007，369：283-292.

11 Merwick A，Albers GW，Amarenco P，et al. Addition

of brain and carotid imaging to the ABCD(2) score to

identify patients at early risk of stroke after transient

ischaemic attack：a multicentre observational study[J].

Lancet Neurol，2010，9：1060-1069.

12 Rothwell PM，Giles MF，Flossmann E，et al. A

simple score (ABCD) to identify individuals at high

early risk of stroke after transient ischaemic attack[J].

Lancet，2005，366：29-36.

13 Yang J，Fu JH，Chen XY，et al. Validation of the

ABCD2 score to identify the patients with high risk of

late stroke after a transient ischemic attack or minor

ischemic stroke[J]. Stroke，2010，41：1298-1300.

14 Coutts SB，Eliasziw M，Hill MD，et al. An improved

scoring system for identifying patients at high early

risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke[J]. Int

J Stroke，2008，3：3-10.

15 Giles MF，Albers GW，Amarenco P，et al. Addition

of brain infarction to the ABCD2 Score (ABCD2I)：a

collaborative analysis of unpublished data on 4574

patients[J]. Stroke，2010，41：1907-1913.

16 Zhang C，Zhao X，Wang C，et al. Prediction factors

of recurrent ischemic events in one year after minor

stroke[J]. PLoS One，2015，10：e0120105.

17 Horton M，Modi J，Patel SK，et al. Refinement of

imaging predictors of recurrent events following

transient ischemic attack and minor stroke[J]. PLoS

One，2013，8：e65752.

18 Co u t t s SB，Modi J，Pat el SK，e t a l . CT/CT

angiography and MRI findings predict recurrent

stroke after transient ischemic attack and minor stroke：

results of the prospective CATCH study[J]. Stroke，

2012，43：1013-1017.

19 Liu L，Wong KS，Leng X，et al. Dual antiplatelet

therapy in stroke and ICAS：Subgroup analysis of

CHANCE[J]. Neurology，2015，85：1154-1162.

20 Li J，Wang Y，Lin J，et al. Soluble CD40L is a useful

marker to predict future strokes in patients with minor

stroke and transient ischemic attack[J]. Stroke，2015，

46：1990-1992.

21 Lin J，Zheng H，Cucchiara BL，et al. Association of

Lp-PLA2-A and early recurrence of vascular events

after TIA and minor stroke[J]. Neurology，2015，85：

1585-1591.

22 Li J，Wang Y，Wang D，et al. Glycated albumin

predicts the effect of dual and single antiplatelet

therapy on recurrent stroke[J]. Neurology，2015，84：

1330-1336.

23 Giles MF，Rothwell PM. Risk of stroke early after

transient ischaemic attack：a systematic review and

meta-analysis[J]. Lancet Neurol，2007，6：1063-1072.

24 Lovett JK，Dennis MS，Sandercock PA，et al. Very

early risk of stroke after a first transient ischemic

attack[J]. Stroke，2003，34：e138-140.

25 Hill MD，Yiannakoulias N，Jeerakathil T，et al.

The high risk of stroke immediately after transient

ischemic at tack：a populat ion-based study[J].

Neurology，2004，62：2015-2020.

26 Kleindorfer D，Panagos P，Pancioli A，et al. Incidence

and short-term prognosis of transient ischemic attack

in a population-based study[J]. Stroke，2005，36：720-

723.

27 Rothwell PM，Giles MF，Chandratheva A，et al.

Effect of urgent treatment of transient ischaemic

attack and minor stroke on early recurrent stroke

(EXPRESS study)：a prospective population-based sequential comparison[J]. Lancet，2007，370：1432-

1442.

28 Luengo-Fernandez R，Gray AM，Rothwell PM. Effect

of urgent treatment for transient ischaemic attack

and minor stroke on disability and hospital costs

(EXPRESS study)：a prospective population-based

sequential comparison[J]. Lancet Neurol，2009，8：

235-243.

29 Lavallee PC，Meseguer E，Abboud H，et al. A

transient ischaemic attack clinic with round-the-clock

access (SOS-TIA)：feasibility and effects[J]. Lancet

Neurol，2007，6：953-960.

30 Dutta D，Bowen E，Foy C. Four-year follow-up of

transient ischemic attacks，strokes，and mimics：a

retrospective transient ischemic attack clinic cohort

study[J]. Stroke，2015，46：1227-1232.

31 Wasserman J，Perry J，Dowlatshahi D，et al. Stratified，

urgent care for transient ischemic attack results in low

stroke rates[J]. Stroke，2010，41：2601-2605.

32 Olivot JM，Wolford C，Castle J，et al. Two aces：

transient ischemic attack work-up as outpatient

assessment of clinical evaluation and safety[J]. Stroke，

2011，42：1839-1843.

33 Sanders LM，Srikanth VK，Jolley DJ，et al. Monash

transient ischemic attack triaging treatment：safety

of a transient ischemic attack mechanism-based

outpatient model of care[J]. Stroke，2012，43：2936-

2941.

34 Amarenco P，Lavallee PC，Labreuche J，et al. Oneyear

risk of stroke after transient ischemic attack or

minor stroke[J]. N Engl J Med，2016，374：1533-1542.

35 中华医学会神经病学分会，中华医学会神经病学分会

脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发

作二级预防指南2014[J]. 中华神经科杂志，2015，48：

16.

36 Br av a t a DM，Wel l s CK，Ker nan WN，e t a l .

Association between impaired insulin sensitivity and

stroke[J]. Neuroepidemiology，2005，25：69-74.

37 Hankey GJ，Feng TZ. Insulin resistance a possible

causal and treatable risk factor for ischemic stroke[J].

Arch Neurol，2010，67：1177-1178.

38 Rundek T，Gardener H，Xu Q，et al. Insulin resistance

and risk of ischemic stroke among nondiabetic

individuals from the northern Manhattan study[J].

Arch Neurol，2010，67：1195-1200.

39 Thacker EL，Psaty BM，McKnight B，et al. Fasting

and post-glucose load measures of insulin resistance

and risk of ischemic stroke in older adults[J]. Stroke，

2011，42：3347-3351.

40 Kernan WN，Inzucchi SE，Viscoli CM，et al. Insulin

resistance and risk for stroke[J]. Neurology，2002，59：809-815.

41 Bas DF，Ozdemir AO，Colak E，et al. Higher insulin

resistance level is associated with worse clinical

response in acute ischemic stroke patients treated with

intravenous thrombolysis[J]. Transl Stroke Res，2016，

7：167-171.

42 Calleja AI，Garcia-Bermejo P，Cor tijo E，et al.

Insulin resistance is associated with a poor response to

intravenous thrombolysis in acute ischemic stroke[J].

Diabetes Care，2011，34：2413-2417.

43 Ker nan WN，Vi s c ol i CM，Fu r ie KL，e t a l .

Pioglitazone after ischemic stroke or transient ischemic

attack[J]. N Engl J Med，2016，374：1321-1331.

44 Ke r n a n WN，Ovbiagele B，Black HR，e t a l .

Guidelines for the prevention of stroke in patients

with stroke and transient ischemic attack：a guideline

for healthcare professionals from the American Heart

Association/American Stroke Association[J]. Stroke，

2014，45：2160-2236.

45 Rerkasem K，Rothwell PM. Carotid endarterectomy

for symptomatic carotid stenosis[J]. Cochrane

Database Syst Rev，2011，CD001081.

46 Brot t TG，Hobson RW，2nd，Howard G，et al.

Stenting versus endarterectomy for treatment of

carotid-artery stenosis[J]. N Engl J Med，2010，363：

11-23.

47 Lal BK，Beach KW，Roubin GS，et al. Restenosis

after carotid artery stenting and endarterectomy：a

secondar y analysis of CREST，a randomized

controlled trial[J]. Lancet Neurol，2012，11：755-763.

48 Kennedy J，Hill MD，Ryckborst KJ，et al. Fast

assessment of stroke and transient ischaemic attack

to prevent early recurrence (FASTER)：a randomized

controlled pilot trial[J]. Lancet Neurol，2007，6：961-

969.

49 Wang Y，Pan Y，Zhao X，et al. Clopidogrel with

Aspirin in Acute Minor Stroke or Transient Ischemic

Attack (CHANCE) Trial：One-year outcomes[J].

Circulation，2015，132：40-46.

50 Johnston SC，Easton JD，Farrant M，et al. Plateletoriented

inhibition in new TIA and minor ischemic

stroke (POINT) trial：rationale and design[J]. Int J

Stroke，2013，8：479-483.

51 Wong KSL，Wang Y，Leng X，et al. Early dual versus

mono antiplatelet therapy for acute non-cardioembolic

ischemic stroke or transient ischemic attack：An

updated systematic review and meta-analysis[J].

Circulation，2013，128：1656-1666.

52 Zhang Q，Wang C，Zheng M，et al. Aspirin plus

clopidogrel as secondary prevention after stroke or

transient ischemic attack：a systematic review and meta-analysis[J]. Cerebrovasc Dis，2015，39：13-22.

53 Gouya G，Arrich J，Wolzt M，et al. Antiplatelet

treatment for prevention of cerebrovascular events in

patients with vascular diseases：a systematic review

and meta-analysis[J]. Stroke，2014，45：492-503.

54 Geeganage CM，Diener HC，Algra A，et al. Dual

or mono antiplatelet therapy for patients with

acute ischemic stroke or transient ischemic attack：

systematic review and meta-analysis of randomized

controlled trials[J]. Stroke，2012，43：1058-1066.

55 Ge F，Lin H，Liu Y，et al. Dual antiplatelet therapy

after stroke or transient ischaemic attack - how long

to treat? The duration of aspirin plus clopidogrel in

stroke or transient ischaemic attack：a systematic

review and meta-analysis[J]. Eur J Neurol，2016，23：

1051-1057.

56 Chen S，Shen Q，Tang Y，et al. Efficacy and safety

of adding clopidogrel to aspirin on stroke prevention

among high vascular risk patients：a meta-analysis of

randomized controlled trials[J]. PLoS One，2014，9：

e104402.

57 Bakheet MF，Pearce LA，Hart RG. Effect of addition

of clopidogrel to aspirin on subdural hematoma：

meta-analysis of randomized clinical trials[J]. Int J

Stroke，2015，10：501-505.

58 Johnston SC，Amarenco P，Albers GW，et al.

Ticagrelor versus aspirin in acute stroke or transient

ischemic attack[J]. N Engl J Med，2016，Epub ahead

of print.

59 Chimowitz MI，Lynn MJ，Howlett-Smith H，et al.

Comparison of warfarin and aspirin for symptomatic

intracranial arterial stenosis[J]. N Engl J Med，2005，

352：1305-1316.

60 Amarenco P，Davis S，Jones EF，et al. Clopidogrel

plus aspirin versus warfarin in patients with stroke

and aortic arch plaques[J]. Stroke，2014，45：1248-

1257.

61 The Boston Area Anticoagulation Trial for Atrial

Fibrillation Investigators. The effect of low-dose

warfarin on the risk of stroke in patients with

nonrheumatic atrial fibrillation[J]. N Engl J Med，

1990，323：1505-1511.

62 Ezekowitz MD，Bridgers SL，James KE，et al.

Warfarin in the prevention of stroke associated

with nonrheumatic atrial f ibrillation. Veterans

Affairs Stroke Prevention in Nonrheumatic Atrial

Fibrillation Investigators[J]. N Engl J Med，1992，

327：1406-1412.

63 Risk factors for stroke and efficacy of antithrombotic

therapy in atrial fibrillation. Analysis of pooled data

from five randomized controlled trials[J]. Arch Intern Med，1994，154：1449-1457.

64 McCormick D，Gurwitz JH，Goldberg RJ，et al.

Prevalence and quality of warfarin use for patients

with atrial fibrillation in the long-term care setting[J].

Arch Intern Med，2001，161：2458-2463.

65 Birman-Deych E，Radford MJ，Nilasena DS，et

al. Use and effectiveness of warfarin in Medicare

beneficiaries with atrial fibrillation[J]. Stroke，2006，

37：1070-1074.

66 Wang C，Yang Z，Wang C，et al. Significant underuse

of warfarin in patients with nonvalvular atrial

fibrillation：results from the China national stroke

registry[J]. J Stroke Cerebrovasc Dis，2014，23：1157-

1163.

67 Yang X，Li Z，Zhao X，et al. Use of warfarin at

discharge among acute ischemic stroke patients with

nonvalvular atrial fibrillation in China[J]. Stroke，

2016，47：464-470.

68 EAFT (European Atrial Fibrillation Trial) Study

Group. Secondary prevention in non-rheumatic atrial

fibrillation after transient ischaemic attack or minor

stroke[J]. Lancet，1993，342：1255-1262.

69 Yu AY，Hill MD，Coutts SB. Should minor stroke

patients be thrombolyzed? A focused review and

future directions[J]. Int J Stroke，2015，10：292-297.

70 Coutts SB，Dubuc V，Mandzia J，et al. Tenecteplasetissue-

type plasminogen activator evaluation for

minor ischemic stroke with proven occlusion[J].

Stroke，2015，46：769-774.

71 National Institute of Neurological Disorders Stroke rt

PASSG. Recombinant tissue plasminogen activator for

minor strokes：the National Institute of Neurological

Disorders and Stroke rt-PA Stroke Study experience[J].

Ann Emerg Med，2005，46：243-252.

72 Khatri P，Kleindorfer DO，Yeatts SD，et al. Strokes

with minor symptoms：an exploratory analysis of

the National Institute of Neurological Disorders and

Stroke recombinant tissue plasminogen activator

trials[J]. Stroke，2010，41：2581-2586.

73 Khat ri P，Tayama D，Cohen G，et al. Effect of

intravenous recombinant tissue-type plasminogen

activator in patients with mild stroke in the Third

International Stroke Trial-3：Post hoc analysis[J].

Stroke，2015，46：2325-2327.

74 Romano JG，Smith EE，Liang L，et al. Outcomes in

mild acute ischemic stroke treated with intravenous thrombolysis：a retrospective analysis of the Get

With the Guidelines-Stroke regist ry[J]. JAMA

Neurol，2015，72：423-431.

75 Choi JC，Jang MU，Kang K，et al. Comparative

effectiveness of standard care with IV thrombolysis

versus without IV thrombolysis for mild ischemic

stroke[J]. J Am Heart Assoc，2015，4：e001306.

76 Logallo N，Kvistad CE，Naess H，et al. Mild

stroke：safety and outcome in patients receiving

thrombolysis[J]. Acta Neurol Scand Suppl，2014，129：

37-40.

77 Greisenegger S，Seyfang L，Kiechl S，e t a l .

Thrombolysis in patients with mild stroke：results

from the Austrian Stroke Unit Registry[J]. Stroke，

2014，45：765-769.

78 Engelter ST，Amort M，Jax F，et al. Optimizing the

risk estimation after a transient ischaemic attack -

the ABCDE plus sign in circle score[J]. Eur J Neurol，

2012，19：55-61.

79 Hankey GJ，Slattery JM，Warlow CP. Transient

ischaemic attacks：which patients are at high (and low)

risk of serious vascular events?[J]. J Neurol Neurosurg

Psychiatry，1992，55：640-652.

80 Predictors of major vascular events in patients with a

transient ischemic attack or nondisabling stroke. The

Dutch TIA Trial Study Group[J]. Stroke，1993，24：

527-531.

81 van Wijk I，Kappelle LJ，van Gijn J，et al. Longterm

survival and vascular event risk after transient

ischaemic attack or minor ischaemic stroke：a cohort

study[J]. Lancet，2005，365：2098-2104.

82 Diener HC，Ringleb PA，Savi P. Clopidogrel for

the secondary prevention of stroke[J]. Expert Opin

Pharmacother，2005，6：755-764.

83 Ay H，Gungor L，Arsava EM，et al. A score to predict

early risk of recurrence after ischemic stroke[J].

Neurology，2010，74：128-135.

84 Kamouchi M，Kumagai N，Okada Y，et al. Risk score

for predicting recurrence in patients with ischemic

stroke: the Fukuoka Stroke Risk Score for Japanese[J].

Cerebrovasc Dis，2012，34: 351-357.

85 Wu L，Wang A，Wang X，et al. Factors for shortterm

outcomes in patients with a minor stroke:

results from China National Stroke Registry[J]. BMC

Neurol，2015，15: 253.